Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand
© 2016 Informa UK Limited, trading as Taylor & Francis Group. Objective: With a high prevalence of chronic kidney disease (CKD) in type 2 diabetes (T2DM) in Thailand, the appropriate treatment for the patients has become a major concern. This study aimed to evaluate long-term cost-effective of...
Saved in:
Main Authors: | Permsuwan U., Dilokthornsakul P., Thavorn K., Saokaew S., Chaiyakunapruk N. |
---|---|
格式: | 雜誌 |
出版: |
2017
|
在線閱讀: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84989259700&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/40821 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand
由: Unchalee Permsuwan, et al.
出版: (2018) -
Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand
由: Unchalee Permsuwan, et al.
出版: (2018) -
Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand
由: Permsuwan U., et al.
出版: (2017) -
Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand
由: Unchalee Permsuwan, et al.
出版: (2018) -
Combined dipeptidyl peptidase-4 inhibitor with low-dose testosterone exerts greater efficacy than monotherapy on improving brain function in orchiectomized obese rats
由: Puntarik Keawtep, et al.
出版: (2019)